Evidence map›Paper›PMID 41675047›Full record

ArticleiScience2026

Prognostic impact of PM

Ziyuan Shen, Feng Zhang, Yujin Zeng, Xing Xing, Shuo Zhang, Chunling Wang, Linyan Xu, Hongfeng Ge, Wanchuan Zhuang, Wei Sang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ziyuan ShenClinical Research Institute, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221006, China.
Feng ZhangReproductive Medical Center, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China.
Yujin ZengDepartment of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221006, China.
Xing XingDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Shuo ZhangDepartment of Hematology, Linyi People's Hospital, Linyi, Shandong 276002, China.
Chunling WangDepartment of Hematology, The First People's Hospital of Huai'an, Huai'an, Jiangsu 223300, China.
Linyan XuDepartment of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221006, China.
Hongfeng GeDepartment of Hematology, Bozhou People's Hospital, Bozhou, Anhui 236800, China.
Wanchuan ZhuangDepartment of Hematology, Affiliated Lianyungang Clinical College of Nantong University, Lianyungang, Jiangsu 222006, China.
Wei SangDepartment of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221006, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prognostic impact of exposure to PM

Indexed as

health sciences

Identifiers

PMID41675047
PMCPMC12886511

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.